Net Cash Provided by (Used in) Operating Activities of KESTRA MEDICAL TECHNOLOGIES, LTD. from 30 Apr 2024 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Apr 2024 to 31 Jul 2025.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Jul 2025 was $26,274,000, a 50% decline year-over-year.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $77,608,000, a 7.4% decline from 2023.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $26,274,000 -$8,775,000 -50% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q1
Q2 2024 $17,499,000 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q1

KESTRA MEDICAL TECHNOLOGIES, LTD. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $77,608,000 -$5,373,000 -7.4% 01 May 2024 30 Apr 2025 10-K 17 Jul 2025 2025 FY
2023 $72,235,000 01 May 2023 30 Apr 2024 10-K 17 Jul 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.